Simple Plasma Test Based on a MoSe<sub>2</sub> SERS Platform for the Specific Diagnosis of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Simple Plasma Test Based on a MoSe₂ SERS Platform for the Specific Diagnosis of Alzheimer’s Disease

Published:2023-05-09 Issue:2 Volume:1 Page:186-191
ISSN:2832-3637
Container-title:Chemical & Biomedical Imaging
language:en
Short-container-title:Chemical & Biomedical Imaging

Author:

Zhou Yan¹,Li Jianyan²,Zheng Tingting²^ORCID,Tian Yang¹²^ORCID

Affiliation:

1. State Key Laboratory of Precision Spectroscopy, East China Normal University, Dongchuan Road 500, Shanghai 200241, P. R. China

2. Shanghai Key Laboratory of Green Chemistry and Chemical Processes, Department of Chemistry, School of Chemistry and Molecular Engineering, East China Normal University, Dongchuan Road 500, Shanghai 200241, P. R. China

Funder

Shanghai Municipal Education Commission

National Natural Science Foundation of China

Shanghai Rising-Star Program

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/cbmi.3c00041

Reference27 articles.

1. The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

2. Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease

3. Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

4. OUP accepted manuscript

5. Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in multi-target fluorescent probes for imaging and analyzing biomarkers in Alzheimer’s disease;Coordination Chemistry Reviews;2024-10

2. A Review of Fabrication of DNA Origami Plasmonic Structures for the Development of Surface-Enhanced Raman Scattering (SERS) Platforms;Plasmonics;2023-09-27

3. Emerging nanotechnology for Alzheimer's disease: From detection to treatment;Journal of Controlled Release;2023-08